Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 164 recruiting now full pipeline #13 of 28,963 conditions

Heart Failure: full-pipeline trial registry

164 of 399 indexed Heart Failure trials are currently recruiting.

Corpus placement: #13 of 28,963 conditions by registered trial count.

399 US clinical trials · 164 currently recruiting · #13 of 28,963 conditions by registered trial count

Heart Failure: 399 US clinical trials tracked, 164 recruiting.

Heart Failure is the subject of 399 registered US clinical trials on ClinicalTrials.gov, 164 of them currently open to new participants. 47 are in Phase 3-4 (later-stage) and 63 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 15 of these trials.

Open enrollment snapshot

Heart Failure has 399 registered US clinical trials, 164 of them open to new participants right now, about 41% of the total.

164
recruiting participants now
41%
of trials open to enrollment
47
in Phase 3-4 (later-stage)
15
top sponsor: Abbott Medical Devices

Corpus placement: #13 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Heart Failure on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Heart Failure is recruiting above its size-band peers.

    164 of 399 indexed trials (41.1%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Heart Failure trials is spread across many organizations.

    Abbott Medical Devices accounts for 15 of 399 trials (3.8%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Heart Failure enrolment sits around 128 participants.

    Median target enrolment is 128 among the 398 trials that report a genuine target (sentinel values excluded). 177 of those (44.5%) plan for fewer than 100 participants.

  4. Heart Failure research is mostly interventional.

    297 interventional and 102 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 128Phase 235Phase 324Phase 423

Open and recent trials

399 total, page 8 of 8

COMPLETED NA 31 participants

Mobile Health Monitoring Solution for Heart Failure Patients

Atlantic Health System

NCT02594007

COMPLETED NA 31 participants

Daxor - Blood Volume Analysis

Duke University

NCT04111185

COMPLETED 31 participants

Reverse Electrical Remodeling of Native Conduction in Cardiac Resynchronization Therapy

Johns Hopkins University

NCT01924221

COMPLETED Phase 2 30 participants

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

Palak Shah

NCT04865978

COMPLETED NA 30 participants

A Tele-Health Symptom Management Program for Patients With Heart Failure: Pall-Heart

University of Virginia

NCT04120857

COMPLETED Phase 2 30 participants

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation

Deborah Ascheim

NCT01442129

COMPLETED NA 27 participants

Rehabilitation and Exercise Training After Hospitalization

Wake Forest University

NCT01508650

COMPLETED Phase 3 27 participants

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

scPharmaceuticals

NCT03458325

COMPLETED Phase 4 26 participants

The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

Josef Stehlik

NCT05420012

COMPLETED 26 participants

M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program

M.D. Anderson Cancer Center

NCT00827801

COMPLETED NA 25 participants

Beta-2 Polymorphisms and Beta Receptor Selectivity

University of Wisconsin, Madison

NCT00214318

COMPLETED 24 participants

Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation

Intersection Medical

NCT02191696

COMPLETED Phase 1 24 participants

Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

Mayo Clinic

NCT04996719

COMPLETED 23 participants

Monitoring Subjects With Fluid-Management Issues In the Home Environment

Baxter Healthcare Corporation

NCT02190877

COMPLETED NA 23 participants

Pericardial Resection to Treat Heart Failure

Mayo Clinic

NCT03073668

COMPLETED Phase 2 21 participants

Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures

Medtronic Cardiac Rhythm and Heart Failure

NCT01370564

COMPLETED NA 21 participants

Nutritional Therapy for Autonomic Dysfunction in Elderly Heart Failure Patients

University of Arkansas

NCT06256276

COMPLETED NA 21 participants

Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function

University of California, San Diego

NCT01671514

COMPLETED Phase 4 21 participants

Pilot Study of Using Copeptin to Predict Response to Tolvaptan

University of North Carolina, Chapel Hill

NCT01346072

COMPLETED Phase 2 21 participants

Oral Nitrite for Older Heart Failure Patients

Gladwin, Mark, MD

NCT02457260

COMPLETED Phase 2 20 participants

Nesiritide and Vo2 Max in Heart Failure Patients

University of Rochester

NCT00240084

COMPLETED NA 20 participants

ECG Belt to Assess Electrical Synchronization

Pugazhendhi Vijayaraman

NCT04583709

COMPLETED Phase 4 20 participants

Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure

Sarfez Pharmaceuticals

NCT06995144

COMPLETED Phase 2 20 participants

The CASCADE HF Soft Launch and Calibration Phase I and II

Endeavor Health

NCT04738279

COMPLETED Phase 1 19 participants

Abdominal Nerve Blockade in Chronic Heart Failure.

Duke University

NCT03453151

COMPLETED 19 participants

Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)

University of Wisconsin, Madison

NCT00585806

COMPLETED 19 participants

Sex and Obesity: Effects on Heart Failure Study

Washington University School of Medicine

NCT00776035

COMPLETED NA 18 participants

Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families

Icahn School of Medicine at Mount Sinai

NCT01427634

COMPLETED Phase 1 17 participants

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

Trevena

NCT01444872

COMPLETED Phase 1 17 participants

Dietary Nitrate for Heart Failure

Washington University School of Medicine

NCT01682356

COMPLETED NA 16 participants

Pressure Variability Study

Medtronic Cardiac Rhythm and Heart Failure

NCT02943941

COMPLETED 16 participants

Study of Left Ventricular Dyssynchrony in Heart Failure Patients

Albert Einstein Healthcare Network

NCT00953953

COMPLETED NA 16 participants

Interventions to Improve Daily Activity in Heart Failure

Grand Valley State University

NCT02331524

COMPLETED NA 15 participants

Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal

Piedmont Healthcare

NCT01287234

COMPLETED NA 15 participants

The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment

University of Utah

NCT00585091

COMPLETED NA 15 participants

Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure

Tufts Medical Center

NCT03001674

COMPLETED Phase 4 14 participants

Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement

Stanford University

NCT01717209

COMPLETED Phase 4 13 participants

Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure

University of North Carolina, Chapel Hill

NCT01925703

COMPLETED Phase 2 12 participants

Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF

University of Pennsylvania

NCT02256345

COMPLETED Phase 1 12 participants

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

Amgen

NCT03318809

COMPLETED Phase 2 11 participants

AZD8601 Study in CABG Patients

AstraZeneca

NCT03370887

COMPLETED NA 11 participants

A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure

Yale University

NCT02031354

COMPLETED Phase 1 10 participants

Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices

University of Utah

NCT02547766

COMPLETED Phase 2 10 participants

Myocardial Hemodynamic Effects of Levosimendan

University of Utah

NCT00585104

COMPLETED NA 7 participants

Rural Home Hospital: Proof of Concept

Brigham and Women's Hospital

NCT04531280

COMPLETED Phase 1 7 participants

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

M.D. Anderson Cancer Center

NCT02408432

COMPLETED 6 participants

Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy

University of Florida

NCT02083419

COMPLETED NA 2 participants

Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients

Loma Linda University

NCT04452578

COMPLETED NA 1 participants

Lymph Drainage in Heart Failure

Duke University

NCT05240638

← Previous Page 8 of 8

Phase Distribution

PhaseTrial count
Phase 1 28
Phase 2 35
Phase 3 24
Phase 4 23

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Heart Failure right now

164 recruiting of 399 indexed (41% open).

Phase mix: 47 late (III/IV) vs 63 early (I/II) (balanced across stages).

Top sponsor: Abbott Medical Devices (15 trials), 9 others listed. 49 shown below, recruiting first. #13 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Heart Failure?

PlainTrial tracks 399 US clinical trials for Heart Failure, of which 164 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Heart Failure?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.